BOSTON SCIENTIFIC CORP — Director's Dealing 2020

Oct 5, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2020-10-05

Reporting Person: BOSTON SCIENTIFIC CORP (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-05	Common Stock	C	3787878.0000	$0.0000	Acquired	3788019.0000	Direct
2020-10-05	Common Stock	C	2081909.0000	$0.0000	Acquired	5869928.0000	Direct
2020-10-05	Common Stock	C	47536.0000	$0.0000	Acquired	5917464.0000	Direct
2020-10-05	Common Stock	C	40705.0000	$0.0000	Acquired	5958169.0000	Direct
2020-10-05	Common Stock	C	23180.0000	$0.0000	Acquired	5981349.0000	Direct
2020-10-05	Common Stock	C	6215.0000	$0.0000	Acquired	5987564.0000	Direct
2020-10-05	Common Stock	C	542.0000	$0.0000	Acquired	5988106.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-05	Series A-1 Preferred Stock	$	C	40705.0000	Disposed		Common Stock (40705.0000)	Direct
2020-10-05	Series B-1 Preferred Stock	$	C	47536.0000	Disposed		Common Stock (47536.0000)	Direct
2020-10-05	Series C-1 Preferred Stock	$	C	23180.0000	Disposed		Common Stock (23180.0000)	Direct
2020-10-05	Series D-1 Preferred Stock	$	C	542.0000	Disposed		Common Stock (542.0000)	Direct
2020-10-05	Series E-1 Preferred Stock	$	C	6215.0000	Disposed		Common Stock (6215.0000)	Direct
2020-10-05	Series F-1 Preferred Stock	$	C	3787878.0000	Disposed		Common Stock (3787878.0000)	Direct
2020-10-05	Series G-1 Preferred Stock	$	C	2081909.0000	Disposed		Common Stock (2081909.0000)	Direct

Footnotes

F1: The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date.